These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 29874556)

  • 1. Autophagy induced by overexpression of DCTPP1 promotes tumor progression and predicts poor clinical outcome in prostate cancer.
    Lu J; Dong W; He H; Han Z; Zhuo Y; Mo R; Liang Y; Zhu J; Li R; Qu H; Zhang L; Wang S; Ma R; Jia Z; Zhong W
    Int J Biol Macromol; 2018 Oct; 118(Pt A):599-609. PubMed ID: 29874556
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High expression of ASPM correlates with tumor progression and predicts poor outcome in patients with prostate cancer.
    Xie JJ; Zhuo YJ; Zheng Y; Mo RJ; Liu ZZ; Li BW; Cai ZD; Zhu XJ; Liang YX; He HC; Zhong WD
    Int Urol Nephrol; 2017 May; 49(5):817-823. PubMed ID: 28213802
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enhanced expression of centromere protein F predicts clinical progression and prognosis in patients with prostate cancer.
    Zhuo YJ; Xi M; Wan YP; Hua W; Liu YL; Wan S; Zhou YL; Luo HW; Wu SL; Zhong WD; Wu CL
    Int J Mol Med; 2015 Apr; 35(4):966-72. PubMed ID: 25647485
    [TBL] [Abstract][Full Text] [Related]  

  • 4. SNORA42 enhances prostate cancer cell viability, migration and EMT and is correlated with prostate cancer poor prognosis.
    Yi C; Wan X; Zhang Y; Fu F; Zhao C; Qin R; Wu H; Li Y; Huang Y
    Int J Biochem Cell Biol; 2018 Sep; 102():138-150. PubMed ID: 30053504
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Overexpression of long non-coding RNA LOC400891 promotes tumor progression and poor prognosis in prostate cancer.
    Wang J; Cheng G; Li X; Pan Y; Qin C; Yang H; Hua L; Wang Z
    Tumour Biol; 2016 Jul; 37(7):9603-13. PubMed ID: 26797783
    [TBL] [Abstract][Full Text] [Related]  

  • 6.
    Cai C; Luo J; Liu Q; Liu Z; Zhao Y; Wu X; Yuegao Y; Lei Y; Lu J; Wang Y; Cai Z; Duan X; Lei M; Gu D; Liu Y
    Genet Test Mol Biomarkers; 2021 Feb; 25(2):131-139. PubMed ID: 33596143
    [No Abstract]   [Full Text] [Related]  

  • 7. Silencing DSCAM-AS1 suppresses the growth and invasion of ER-positive breast cancer cells by downregulating both DCTPP1 and QPRT.
    Yue Z; Shusheng J; Hongtao S; Shu Z; Lan H; Qingyuan Z; Shaoqiang C; Yuanxi H
    Aging (Albany NY); 2020 Jul; 12(14):14754-14774. PubMed ID: 32716908
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MicroRNA-132/212 Upregulation Inhibits TGF-β-Mediated Epithelial-Mesenchymal Transition of Prostate Cancer Cells by Targeting SOX4.
    Fu W; Tao T; Qi M; Wang L; Hu J; Li X; Xing N; Du R; Han B
    Prostate; 2016 Dec; 76(16):1560-1570. PubMed ID: 27527117
    [TBL] [Abstract][Full Text] [Related]  

  • 9. βKlotho inhibits androgen/androgen receptor‑associated epithelial‑mesenchymal transition in prostate cancer through inactivation of ERK1/2 signaling.
    Liu Z; Zhang H; Ding S; Qi S; Liu S; Sun D; Dong W; Yin L; Li M; Zhao X; Lu J
    Oncol Rep; 2018 Jul; 40(1):217-225. PubMed ID: 29749458
    [TBL] [Abstract][Full Text] [Related]  

  • 10. E2F1 promotes tumor cell invasion and migration through regulating CD147 in prostate cancer.
    Liang YX; Lu JM; Mo RJ; He HC; Xie J; Jiang FN; Lin ZY; Chen YR; Wu YD; Luo HW; Luo Z; Zhong WD
    Int J Oncol; 2016 Apr; 48(4):1650-8. PubMed ID: 26891801
    [TBL] [Abstract][Full Text] [Related]  

  • 11. DCTPP1 attenuates the sensitivity of human gastric cancer cells to 5-fluorouracil by up-regulating MDR1 expression epigenetically.
    Xia LL; Tang YB; Song FF; Xu L; Ji P; Wang SJ; Zhu JM; Zhang Y; Zhao GP; Wang Y; Liu TT
    Oncotarget; 2016 Oct; 7(42):68623-68637. PubMed ID: 27612427
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enhanced expression of SRPK2 contributes to aggressive progression and metastasis in prostate cancer.
    Zhuo YJ; Liu ZZ; Wan S; Cai ZD; Xie JJ; Cai ZD; Song SD; Wan YP; Hua W; Zhong W; Wu CL
    Biomed Pharmacother; 2018 Jun; 102():531-538. PubMed ID: 29587239
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long non-coding RNA ATB promotes growth and epithelial-mesenchymal transition and predicts poor prognosis in human prostate carcinoma.
    Xu S; Yi XM; Tang CP; Ge JP; Zhang ZY; Zhou WQ
    Oncol Rep; 2016 Jul; 36(1):10-22. PubMed ID: 27176634
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HMGCS2 functions as a tumor suppressor and has a prognostic impact in prostate cancer.
    Wan S; Xi M; Zhao HB; Hua W; Liu YL; Zhou YL; Zhuo YJ; Liu ZZ; Cai ZD; Wan YP; Zhong WD
    Pathol Res Pract; 2019 Aug; 215(8):152464. PubMed ID: 31176575
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of human dCTP pyrophosphatase 1 (DCTPP1) and its association with cisplatin resistance characteristics in ovarian cancer.
    Wang Y; Chen X; Chen Q; Liu T; Wu Y; Huang L; Chen Y
    J Cell Mol Med; 2024 May; 28(9):e18371. PubMed ID: 38686496
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Overexpression of MCM10 promotes cell proliferation and predicts poor prognosis in prostate cancer.
    Cui F; Hu J; Ning S; Tan J; Tang H
    Prostate; 2018 Dec; 78(16):1299-1310. PubMed ID: 30095171
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MicroRNA-224 inhibits progression of human prostate cancer by downregulating TRIB1.
    Lin ZY; Huang YQ; Zhang YQ; Han ZD; He HC; Ling XH; Fu X; Dai QS; Cai C; Chen JH; Liang YX; Jiang FN; Zhong WD; Wang F; Wu CL
    Int J Cancer; 2014 Aug; 135(3):541-50. PubMed ID: 24382668
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human dCTP pyrophosphatase 1 promotes breast cancer cell growth and stemness through the modulation on 5-methyl-dCTP metabolism and global hypomethylation.
    Song FF; Xia LL; Ji P; Tang YB; Huang ZM; Zhu L; Zhang J; Wang JQ; Zhao GP; Ge HL; Zhang Y; Wang Y
    Oncogenesis; 2015 Jun; 4(6):e159. PubMed ID: 26075750
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Decreased expression of serine protease inhibitor family G1 (SERPING1) in prostate cancer can help distinguish high-risk prostate cancer and predicts malignant progression.
    Peng S; Du T; Wu W; Chen X; Lai Y; Zhu D; Wang Q; Ma X; Lin C; Li Z; Guo Z; Huang H
    Urol Oncol; 2018 Aug; 36(8):366.e1-366.e9. PubMed ID: 29903461
    [TBL] [Abstract][Full Text] [Related]  

  • 20. miR-195 Inhibits Tumor Progression by Targeting RPS6KB1 in Human Prostate Cancer.
    Cai C; Chen QB; Han ZD; Zhang YQ; He HC; Chen JH; Chen YR; Yang SB; Wu YD; Zeng YR; Qin GQ; Liang YX; Dai QS; Jiang FN; Wu SL; Zeng GH; Zhong WD; Wu CL
    Clin Cancer Res; 2015 Nov; 21(21):4922-34. PubMed ID: 26080838
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.